Assessing the prevalence of neutralizing antibodies (NAbs) to SARS-CoV-2 during three years of the COVID-19 pandemic. - Barreto MDS; Santos RS; Dias Silva EE; Rego Rodrigues Silva DM; Macedo Moura PH; de Jesus PC; de Souza JB; da Mota Santana LA; Guimarães AG; Borges LP (Biochemistry and biophysics reports, 2024)